Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 13;24(1):170.
doi: 10.1186/s12882-023-03191-5.

Association between serum β2-microglobulin levels and the risk of all-cause and cardiovascular disease mortality in chinese patients undergoing maintenance hemodialysis

Yu-Xin Jin  1   2   3 , Shuang Zhang  2   3 , Jia Xiao  2   3 , Zhi-Hong Wang  2   3 , Cui Dong  2   3 , Lian-Lian You  2   3 , Ting-Ting Kuai  2   3 , Yu Zhang  2   3 , Shu-Xin Liu  4   5   6
Affiliations

Association between serum β2-microglobulin levels and the risk of all-cause and cardiovascular disease mortality in chinese patients undergoing maintenance hemodialysis

Yu-Xin Jin et al. BMC Nephrol. .

Abstract

Background: The association between serum β2-microglobulin (β2M) levels and the risk of all-cause and cardiovascular disease (CVD) mortality and the incidence of cardiovascular events (CVEs) in patients undergoing maintenance hemodialysis (MHD) is inconclusive. Furthermore, no study has been performed in China on the significance of serum β2M levels in MHD patients. Therefore, this study investigated the aforementioned association in MHD patients.

Methods: In this prospective cohort study, 521 MHD patients were followed at Dalian Municipal Central Hospital affiliated with Dalian University of Technology from December 2019 to December 2021. The serum β2M levels were categorized into three tertiles, and the lowest tertile served as the reference group. Survival curves were calculated by the Kaplan-Meier method. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using Cox proportional hazard models. Sensitivity analysis was performed by excluding patients with CVD at baseline.

Results: During the follow-up period of 21.4 ± 6.3 months, there were 106 all-cause deaths, of which 68 were caused by CVD. When excluding CVD patients at baseline, there were 66 incident CVEs. Kaplan-Meier analysis revealed that the risk of all-cause and CVD mortality in the highest tertile of serum β2M levels was significantly higher than that in the lowest tertile (P < 0.05), but not for the CVEs (P > 0.05). After adjusting for potential confounders, serum β2M levels were positively associated with the risk of all-cause (HR = 2.24, 95% CI = 1.21-4.17) and CVD (HR = 2.54, 95% CI = 1.19-5.43) mortality, and a linear trend was evident (P < 0.05). Besides, the results of sensitivity analysis were consistent with the main findings. However, we didn't observed the significant association between serum β2M levels and CVEs (P > 0.05).

Conclusion: The serum β2M level may be a significant predictor of the risk of all-cause and CVD mortality in MHD patients. Further studies are needed to confirm this finding.

Keywords: Cardiovascular events; Cohort study; Hemodialysis; Mortality; β2-microglobulin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
Flow chart indicates patient enrollment
Fig. 2
Fig. 2
Kaplan–Meier analysis of all-cause mortality of 521 maintenance hemodialysis patients, classified according to tertiles of serum β2M levels
Fig. 3
Fig. 3
Kaplan–Meier analysis of cardiovascular disease mortality of 521 maintenance hemodialysis patients, classified according to tertiles of serum β2M levels
Fig. 4
Fig. 4
Kaplan–Meier analysis of cardiovascular events of 335 maintenance hemodialysis patients, classified according to tertiles of serum β2M levels
See this image and copyright information in PMC

References

    1. Andrassy KM. Comments on ‘KDIGO 2012 Clinical Practice Guideline for the evaluation and management of chronic kidney disease’. Kidney Int. 2013 Sep;84(3):622–3. - PubMed
    1. Hole B, Hemmelgarn B, Brown E, Brown M, McCulloch MI, Zuniga C et al. Supportive care for end-stage kidney disease: an integral part of kidney services across a range of income settings around the world. Kidney Int Suppl (2011). 2020 Mar;10(1):e86-e94. - PMC - PubMed
    1. Johansen KL, Chertow GM, Gilbertson DT, Herzog CA, Ishani A, Israni AK, et al. Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2022 Apr;79(4 Suppl 1):A8–A12. US Renal Data System 2021 Annual Data Report:. - PMC - PubMed
    1. Cheng X, Nayyar S, Wang M, Li X, Sun Y, Huang W, et al. Mortality rates among prevalent hemodialysis patients in Beijing: a comparison with USRDS data. Nephrol Dial Transplant. 2013 Mar;28(3):724–32. - PubMed
    1. Jablonski KL, Chonchol M. Recent advances in the management of hemodialysis patients: a focus on cardiovascular disease. F1000Prime Rep. 2014;6:72. doi: 10.12703/P6-72. - DOI - PMC - PubMed

Publication types

Substances